دورية أكاديمية

Discoidin domain receptor 2 regulates aberrant mesenchymal lineage cell fate and matrix organization.

التفاصيل البيبلوغرافية
العنوان: Discoidin domain receptor 2 regulates aberrant mesenchymal lineage cell fate and matrix organization.
المؤلفون: Pagani CA; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Bancroft AC; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Tower RJ; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Livingston N; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Sun Y; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Hong JY; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Kent RN 3rd; Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., Strong AL; Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Nunez JH; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Medrano JMR; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA., Patel N; Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Nanes BA; Department of Dermatology, University of Texas Southwestern, Dallas, TX, USA.; Lydia Hill Department of Bioinformatics, University of Texas Southwestern, Dallas, TX, USA., Dean KM; Lydia Hill Department of Bioinformatics, University of Texas Southwestern, Dallas, TX, USA.; Cecil H. and The Ida Green Center for Systems Biology, University of Texas Southwestern, Dallas, TX, USA., Li Z; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Ge C; School of Dentistry, University of Michigan, Ann Arbor, MI, USA., Baker BM; Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., James AW; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Weiss SJ; Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA., Franceschi RT; School of Dentistry, University of Michigan, Ann Arbor, MI, USA., Levi B; Center for Organogenesis and Trauma, Department of Surgery, University of Texas Southwestern, Dallas, TX, USA.
المصدر: Science advances [Sci Adv] 2022 Dec 21; Vol. 8 (51), pp. eabq6152. Date of Electronic Publication: 2022 Dec 21.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Washington, DC : American Association for the Advancement of Science, [2015]-
مواضيع طبية MeSH: Discoidin Domain Receptor 2*/genetics, Mice ; Animals ; Proteomics ; Cell Differentiation/genetics ; Extracellular Matrix/metabolism ; Signal Transduction/physiology
مستخلص: Extracellular matrix (ECM) interactions regulate both the cell transcriptome and proteome, thereby determining cell fate. Traumatic heterotopic ossification (HO) is a disorder characterized by aberrant mesenchymal lineage (MLin) cell differentiation, forming bone within soft tissues of the musculoskeletal system following traumatic injury. Recent work has shown that HO is influenced by ECM-MLin cell receptor signaling, but how ECM binding affects cellular outcomes remains unclear. Using time course transcriptomic and proteomic analyses, we identified discoidin domain receptor 2 (DDR2), a cell surface receptor for fibrillar collagen, as a key MLin cell regulator in HO formation. Inhibition of DDR2 signaling, through either constitutive or conditional Ddr2 deletion or pharmaceutical inhibition, reduced HO formation in mice. Mechanistically, DDR2 perturbation alters focal adhesion orientation and subsequent matrix organization, modulating Focal Adhesion Kinase (FAK) and Yes1 Associated Transcriptional Regulator and WW Domain Containing Transcription Regulator 1 (YAP/TAZ)-mediated MLin cell signaling. Hence, ECM-DDR2 interactions are critical in driving HO and could serve as a previously unknown therapeutic target for treating this disease process.
References: Nat Genet. 1999 May;22(1):85-9. (PMID: 10319868)
Matrix. 1989;9(6):451-8. (PMID: 2635758)
J Biol Chem. 2018 Apr 20;293(16):5766-5780. (PMID: 29507095)
Nat Commun. 2021 May 25;12(1):3100. (PMID: 34035288)
Dev Cell. 2013 May 28;25(4):402-16. (PMID: 23685250)
Bone. 2013 May;54(1):28-34. (PMID: 23314070)
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E338-47. (PMID: 26721400)
Elife. 2019 May 30;8:. (PMID: 31144616)
Sci Rep. 2017 Jul 28;7(1):6847. (PMID: 28754957)
Curr Protoc Cell Biol. 2010 Sep;Chapter 10:Unit 10.18.1-20. (PMID: 20853341)
J Dent Res. 2021 Nov;100(12):1359-1366. (PMID: 33899571)
Biomacromolecules. 2012 Mar 12;13(3):937-42. (PMID: 22229738)
Bone. 2014 Jan;58:33-41. (PMID: 24120383)
Nat Methods. 2021 Nov;18(11):1333-1341. (PMID: 34725479)
Acta Biomater. 2020 Mar 15;105:78-86. (PMID: 31945504)
Ann Surg. 2014 May;259(5):993-8. (PMID: 23673767)
Transl Res. 2017 Aug;186:95-111. (PMID: 28668522)
Adv Exp Med Biol. 2016;920:3-10. (PMID: 27535244)
J Bone Miner Res. 2016 Dec;31(12):2193-2203. (PMID: 27341689)
J Bone Miner Res. 2011 Mar;26(3):604-17. (PMID: 20734453)
Nat Commun. 2018 Feb 7;9(1):551. (PMID: 29416028)
Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53. (PMID: 18938156)
Sci Transl Med. 2021 Jun 23;13(599):. (PMID: 34162750)
Exp Cell Res. 2016 Apr 10;343(1):14-20. (PMID: 26519907)
Nat Protoc. 2014 Feb;9(2):457-63. (PMID: 24481272)
Nature. 2011 Jun 08;474(7350):179-83. (PMID: 21654799)
J Bone Miner Res. 2010 Nov;25(11):2489-503. (PMID: 20564243)
Front Immunol. 2019 Oct 24;10:2148. (PMID: 31708911)
Cell Rep. 2016 Jun 14;15(11):2510-23. (PMID: 27264173)
Nat Cell Biol. 2019 Dec;21(12):1490-1503. (PMID: 31768046)
Macromol Biosci. 2017 Dec;17(12):. (PMID: 29068543)
Mol Cell. 1997 Dec;1(1):13-23. (PMID: 9659899)
Cell Stem Cell. 2009 Jul 2;5(1):17-26. (PMID: 19570510)
Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
Stem Cell Reports. 2021 Mar 9;16(3):626-640. (PMID: 33606989)
ACS Biomater Sci Eng. 2019 Jun 10;5(6):2965-2975. (PMID: 33405599)
Cell Rep. 2017 Jan 31;18(5):1215-1228. (PMID: 28147276)
Bone Res. 2022 Feb 9;10(1):11. (PMID: 35140200)
Acta Biochim Biophys Sin (Shanghai). 2015 Apr;47(4):292-8. (PMID: 25733533)
Bone. 2018 Apr;109:276-280. (PMID: 28736245)
Biomaterials. 2009 Sep;30(26):4309-17. (PMID: 19477508)
J Dent Res. 2020 Feb;99(2):214-222. (PMID: 31869264)
Fibrogenesis Tissue Repair. 2011 Feb 02;4(1):5. (PMID: 21288331)
Exp Cell Res. 2007 Jan 1;313(1):22-37. (PMID: 17081517)
Science. 1999 Apr 2;284(5411):143-7. (PMID: 10102814)
J Clin Invest. 2020 Oct 1;130(10):5444-5460. (PMID: 32673290)
Curr Osteoporos Rep. 2015 Apr;13(2):116-24. (PMID: 25687936)
Proc Natl Acad Sci U S A. 2017 May 30;114(22):5647-5652. (PMID: 28507138)
Bone. 2010 Feb;46(2):425-31. (PMID: 19735753)
Tissue Eng Part A. 2018 Apr;24(7-8):584-594. (PMID: 28726579)
Bone. 2021 Sep;150:116016. (PMID: 34022457)
Nat Genet. 1995 Jan;9(1):15-20. (PMID: 7704017)
Matrix Biol. 2014 Feb;34:185-92. (PMID: 24361528)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Cell. 1997 May 30;89(5):755-64. (PMID: 9182763)
Cell Adh Migr. 2018;12(4):378-385. (PMID: 29671358)
J Biol Chem. 2000 Apr 14;275(15):10738-44. (PMID: 10753864)
Elife. 2021 Mar 30;10:. (PMID: 33783351)
Biochem Biophys Res Commun. 2012 Oct 26;427(3):611-7. (PMID: 23022180)
Nat Commun. 2020 Feb 5;11(1):722. (PMID: 32024825)
Am J Physiol Cell Physiol. 2002 Mar;282(3):C595-605. (PMID: 11832345)
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7786-E7794. (PMID: 30061414)
J Cell Mol Med. 2013 May;17(5):597-604. (PMID: 23601032)
Stem Cells. 2017 Mar;35(3):705-710. (PMID: 27862618)
Hum Gene Ther. 2010 Oct;21(10):1226-38. (PMID: 20804388)
Nat Methods. 2015 Jul;12(7):653-6. (PMID: 26030446)
J Anat. 2015 Dec;227(6):717-31. (PMID: 25382217)
معلومات مُعتمدة: R01 GM123069 United States GM NIGMS NIH HHS; RM1 GM145399 United States GM NIGMS NIH HHS; U54 CA268072 United States CA NCI NIH HHS; R01 AR071379 United States AR NIAMS NIH HHS; R01 AR078324 United States AR NIAMS NIH HHS; R21 DE029012 United States DE NIDCR NIH HHS; P30 CA142543 United States CA NCI NIH HHS; T32 AR065969 United States AR NIAMS NIH HHS; T32 DE007057 United States DE NIDCR NIH HHS; T32 CA009672 United States CA NCI NIH HHS; R21 HD105189 United States HD NICHD NIH HHS; R01AR071379 United States AR NIAMS NIH HHS; R01 DK127589 United States DK NIDDK NIH HHS; P30 AR069620 United States AR NIAMS NIH HHS; P30 DK020572 United States DK NIDDK NIH HHS; R01 DE029465 United States DE NIDCR NIH HHS
المشرفين على المادة: EC 2.7.10.1 (Discoidin Domain Receptor 2)
تواريخ الأحداث: Date Created: 20221221 Date Completed: 20221223 Latest Revision: 20240510
رمز التحديث: 20240510
مُعرف محوري في PubMed: PMC9770942
DOI: 10.1126/sciadv.abq6152
PMID: 36542719
قاعدة البيانات: MEDLINE
الوصف
تدمد:2375-2548
DOI:10.1126/sciadv.abq6152